Drug: |
CB-839 + Talazoparib |
|||
---|---|---|---|---|
Trial: |
Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors |
|||
Conditions: | Solid Tumors | |||
Trial Status: |
Terminated |
Emory Winship Cancer Institute1365C Clifton Road |
Principal Investigator: |
Manali Bhavi, MD |
---|---|
Contact: |
Manali Bhavi, MD 404-778-1900 manali.ajay.bhave@emory.edu |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Emory Winship Cancer Institute Website: |
http://cancer.emory.edu/ |
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.